A shortened postpartum magnesium sulfate prophylaxis regime in pre‐eclamptic women at low risk of eclampsia

Authors:
  • RJRubi Jose
    Rubi Jose
  • ARAnni Regi
    Anni Regi
  • RBRamandeep Bansal
    Ramandeep Bansal
  • LJLaxmanan Jeyaseelan
    Laxmanan Jeyaseelan

Abstract
Objective: To determine whether magnesium sulfate (MgSO4) prophylaxis is needed for up to 24 hours postpartum in all patients with pre‐eclampsia.Methods: In a randomized open clinical trial conducted in a tertiary health center in India between September 2008 and April 2010, 150 women with severe pre‐eclampsia who received intrapartum MgSO4 and delivered at more than 20 weeks gestation were enrolled. After 6 hours postpartum, the participants were randomized to continue receiving (control group) or to discontinue (intervention group) MgSO4, and outcomes were compared.Results: Administration of MgSO4 had to be reinstituted for 1 woman in the intervention group. Under the current protocol in the institution, all 75 women in the intervention group would have received MgSO4 for 24 hours postpartum. A significant reduction in time spent by the doctors (P < 0.001) and nurses (P < 0.001) was seen in the intervention group. The pain score in the intervention group was significantly less (P < 0.001), and women in the intervention group were able to look after themselves better (P < 0.001).Conclusion: For women at low risk for postpartum eclampsia, a shortened (6‐hour) MgSO4 regime was as effective for seizure prophylaxis as the conventional 24‐hour regime, with significant benefits in terms of cost and morbidity.

This publication has 7 references indexed in Scilit: